Physician
Oncology
Dr. Daniel Lehane, MD
|
|
Give Review
Daniel Lehane practices Oncology. He graduated from Baylor College of Medicine. Dr. Daniel Lehane is also a published MD. He has 37 paper published. The most recent paper is: Ocular and orbital complications of intraarterial cisplatin. A case report. Doctor Daniel Lehane, MD accepts Medicare payments and is listed with Medicare.gov.
Publications
- Preliminary observations of the effects on Breast adenocarcinoma of plasma perfused over immobilized protein A.
- Physical and psychosocial needs of Cancer patients.
- The effect of diuretic pre-treatment on clinical, morphological and ultrastructural cis-platinum induced nephrotoxicity.
- Anxiety in medical situations and chemotherapy-related problems among Cancer patients.
- Small-cell Carcinoma of the lung: combined chemotherapy and radiation: a Southwest Oncology Group study.
- Phase II evaluation of galactitol in head and neck Cancer: a Southwest Oncology Group Study.
- Cis-platinum therapy of previously treated head and neck Cancer: the Southwest Oncology Group's two-dose-per-month outpatient regimen.
- Chemotherapy of disseminated germinal Tumors of the testis--comparison of vinblastine and bleomycin with vincristine, bleomycin, and actinomycin D.
- Comparative trial of combination chemotherapy in extensive squamous Carcinoma of the lung: a Southwest Oncology Group Study.
- Study of tamoxifen in metastatic renal cell Carcinoma and the influence of certain prognostic factors: a Southwest Oncology Group Study.
- Comparison of methotrexate and cisplatin for patients with advanced squamous cell Carcinoma of the head and neck region: a Southwest Oncology Group Study.
- Prinzmetal's angina during 5-fluorouracil chemotherapy.
- Head and neck Cancer. Head and Neck Oncology Workgroup, Legislative Task Force on Cancer in Texas.
- The nitroblue tetrazolium test in patients with advanced neoplastic diseases.
- Phase III comparison of the treatment of advanced gastrointestinal Cancer with bolus weekly 5-FU vs. methyl-CCNU plus bolus weekly 5-FU. A Southwest Oncology Group study.
- Adriamycin (NSC-123127) plus 5-fluorouracil (NSC-19893): a phase I study.
- Primary Liver amyloidosis producing obstructive jaundice.
- Phase I trial of combination methotrexate and methyl-CCNU in patients with advanced neoplastic diseases.
- The effects of bleomycin on immunocompetence in man.
- Two-dimensional polyacrylamide gel electrophoresis of saline-soluble nuclear proteins of leukemic and normal human lymphocyte nuclear proteins.
- Immunocompetence in advanced Cancer patients prior to chemotherapy.
- Vacuolated erythroblasts in hyperosmolar coma.
- Environmental modifications for controlling acute respiratory disease.
- A seroepidemiologic study of infectious mononucleosis. The development of EB virus antibody in a military population.
- Ocular and orbital complications of intraarterial cisplatin. A case report.
- Oral fluorouracil therapy of hepatoma.
- Nuclear and nucleolar ultrastructure of Sézary cells.
- Acquired factor VIII inhibitor in a patient with mycosis fungoides.
- Intraarterial cis-platinum chemotherapy for patients with primary and metastatic Brain tumors.
- Intra-arterial cisplatin treatment of adenoid cystic Carcinoma.
- High-dose chlorozotocin in lung Cancer: a Southwest Oncology Group Phase II Study.
- Concurrent chemotherapy and radiation therapy of selected head and neck squamous cell Carcinomas using bleomycin and hydroxyurea: A Southwest Oncology Group Study.
- Long-term survival and toxicity in small cell lung Cancer. Southwest Oncology Group study.
- Evaluation of rubella herd immunity during an epidemic.
- A plaque method for titration of frog viruses using starch gel overlay.
- Antigenic relationships among frog viruses demonstrated by the plaque reDuction and neutralization kinetics tests.
Procedures Preformed
- Plasmapheresis
- Thoracentesis
Conditions Treated
- Adrenal Gland Cancer
- Anal and Rectal Cancer
- Anemia
- Bile Duct Cancer
- View All
Doctors Specialties
- Medical Oncology
- Oncology
Accepted Insurances
Education
-
Baylor College of Medicine -
University at Buffalo, School of Medicine and Biomedical Sciences
Drug Facts
| NPI NUMBER | 1801939202 | |
| NPPES Provider LastName | LEHANE | |
| NPPES Provider FirstName | DANIEL | |
| NPPES Provider ZIPCode | 770302717 | |
| NPPES Provider State | TX | |
| Specialty Description | Medical Oncology | |
| Total Claim Count | 1065.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 90.0 | |
| Percent Opioid Claims | 8.45 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1801939202 |
| Last Name Of The Provider | LEHANE |
| First Name Of The Provider | DANIEL |
| View All |
Similar Doctors
|
|
Dr. Elizabeth W. Rogg, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Rachna Shroff, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Nicholas Mitsiades, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Rammurti T. Kamble, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Patrick Hwu, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Renata Ferrarotto, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Emer Hanrahan, MD |
|
|
Dr. Mehmet A. Bilen, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Bryan T. Hennessy, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|